{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:35:49Z","timestamp":1755797749883,"version":"3.44.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2020081"],"award-info":[{"award-number":["2020081"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction and purpose<\/jats:title>\n            <jats:p>Re-intervention, either transsphenoidal surgery or radiotherapy, is suggested in patients who are not in remission after primary surgery for acromegaly; however, the evidence is weak. We aimed to assess the remission rate after re-intervention, and complications compared to a comparison group who had undergone primary interventions only.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Patients diagnosed with acromegaly between 2005\u20132021 at Oslo University Hospital were screened for inclusion. The study cohort included patients with two or more interventions. The comparison group included patients not in remission after primary surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of 223 patients with acromegaly, 42 underwent re-interventions (study cohort). At diagnosis, median age was 38 (IQR 29\u201348) years and 41 patients (98%) had a macroadenoma. The comparison group consisted of 49 patients, median age 54 (IQR 44\u201360) years and 37 (76%) had a macroadenoma at diagnosis.<\/jats:p>\n            <jats:p>Re-interventions in the study cohort consisted of surgery, radiotherapy and a combination of these (22, 12 and eight patients). After re-interventions, 22 patients (52%) were in remission and 12 (29%) had reduced disease activity. Seven patients (17%) acquired new hormone deficiencies, two of them corticotroph deficiency. One patient in remission developed spinal fluid leakage and meningitis. There was no significant difference in complications after surgery between the study cohort and the comparison group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Re-interventions were safe and resulted in remission or substantial improvement in most patients. Re-intervention should be considered for patients who would otherwise require lifelong medical treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00701-025-06640-2","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T10:18:19Z","timestamp":1755512299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of acromegaly beyond primary surgery: efficacy and safety of repeat surgery and radiotherapy"],"prefix":"10.1007","volume":"167","author":[{"given":"Shahriar","family":"Atai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Wiedmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Dahlberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Bollerslev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansgar","family":"Heck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"key":"6640_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8111962","author":"A Akirov","year":"2019","unstructured":"Akirov A, Asa SL, Amer L, Shimon I, Ezzat S (2019) The clinicopathological spectrum of acromegaly. J Clin Med. https:\/\/doi.org\/10.3390\/jcm8111962","journal-title":"J Clin Med"},{"key":"6640_CR2","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.wneu.2011.07.012","volume":"77","author":"H Alahmadi","year":"2012","unstructured":"Alahmadi H, Dehdashti AR, Gentili F (2012) Endoscopic endonasal surgery in recurrent and residual pituitary adenomas after microscopic resection. World Neurosurg 77:540\u2013547. https:\/\/doi.org\/10.1016\/j.wneu.2011.07.012","journal-title":"World Neurosurg"},{"key":"6640_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2024.101898","volume":"38","author":"L Albano","year":"2024","unstructured":"Albano L, Losa M, Garbin E, Pompeo E, Barzaghi LR, Mortini P (2024) Efficacy and safety of radiosurgery in acromegaly. Best Pract Res Clin Endocrinol Metab 38:101898. https:\/\/doi.org\/10.1016\/j.beem.2024.101898","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"6640_CR4","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3171\/2017.2.JNS162673","volume":"129","author":"JP Almeida","year":"2018","unstructured":"Almeida JP, Ruiz-Trevino AS, Liang B, Omay SB, Shetty SR, Chen YN, Anand VK, Grover K, Christos P, Schwartz TH (2018) Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature. J Neurosurg 129:404\u2013416. https:\/\/doi.org\/10.3171\/2017.2.JNS162673","journal-title":"J Neurosurg"},{"key":"6640_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00701-022-05456-8","volume":"165","author":"OF Bengtsson","year":"2023","unstructured":"Bengtsson OF, Sunnergren O, Segerhammar I, Forander P, Olsson M, Hulting AL, Stjarne P (2023) Remission, complications, and overall survival in transsphenoidal pituitary surgery-a Swedish single-center experience of 578 patients. Acta Neurochir (Wien) 165:685\u2013692. https:\/\/doi.org\/10.1007\/s00701-022-05456-8","journal-title":"Acta Neurochir (Wien)"},{"key":"6640_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000441980","volume":"103","author":"M Buchfelder","year":"2016","unstructured":"Buchfelder M, Schlaffer SM (2016) Novel techniques in the surgical treatment of Acromegaly: applications and efficacy. Neuroendocrinology 103:32\u201341. https:\/\/doi.org\/10.1159\/000441980","journal-title":"Neuroendocrinology"},{"key":"6640_CR7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/neuros\/nyy178","volume":"84","author":"D Ding","year":"2019","unstructured":"Ding D, Mehta GU, Patibandla MR, Lee CC, Liscak R, Kano H, Pai FY, Kosak M, Sisterson ND, Martinez-Alvarez R, Martinez-Moreno N, Mathieu D, Grills IS, Blas K, Lee K, Cifarelli CP, Katsevman GA, Lee JYK, McShane B, Kondziolka D, Lunsford LD, Vance ML, Sheehan JP (2019) Stereotactic radiosurgery for acromegaly: an international multicenter retrospective cohort study. Neurosurgery 84:717\u2013725. https:\/\/doi.org\/10.1093\/neuros\/nyy178","journal-title":"Neurosurgery"},{"key":"6640_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.mayocp.2021.11.007","volume":"97","author":"N Ershadinia","year":"2022","unstructured":"Ershadinia N, Tritos NA (2022) Diagnosis and treatment of acromegaly: an update. Mayo Clin Proc 97:333\u2013346. https:\/\/doi.org\/10.1016\/j.mayocp.2021.11.007","journal-title":"Mayo Clin Proc"},{"key":"6640_CR9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.4158\/EP09066.ORR","volume":"15","author":"AL Espinosa de los Monteros","year":"2009","unstructured":"Espinosa de los Monteros AL, Gonzalez B, Vargas G, Sosa E, Guinto G, Mercado M (2009) Surgical reintervention in acromegaly: is it still worth trying? Endocr Pract 15:431\u2013437. https:\/\/doi.org\/10.4158\/EP09066.ORR","journal-title":"Endocr Pract"},{"key":"6640_CR10","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1007\/s00701-023-05772-7","volume":"165","author":"CM Falch","year":"2023","unstructured":"Falch CM, Dupont AK, Olarescu NC, Wiedmann M, Dahlberg D, Bollerslev J, Berg-Johnsen J, Heck A (2023) Long-term control of acromegaly after pituitary surgery in South-eastern Norway. Acta Neurochir (Wien) 165:3003\u20133010. https:\/\/doi.org\/10.1007\/s00701-023-05772-7","journal-title":"Acta Neurochir (Wien)"},{"key":"6640_CR11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s11102-021-01198-5","volume":"25","author":"M Fleseriu","year":"2022","unstructured":"Fleseriu M, Barkan A, Del Pilar Schneider M, Darhi Y, de Pierrefeu A, Ribeiro-Oliveira A Jr., Petersenn S, Neggers S, Melmed S (2022) Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States. Pituitary 25:296\u2013307. https:\/\/doi.org\/10.1007\/s11102-021-01198-5","journal-title":"Pituitary"},{"key":"6640_CR12","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH (2016) Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 101:3888\u20133921. https:\/\/doi.org\/10.1210\/jc.2016-2118","journal-title":"J Clin Endocrinol Metab"},{"key":"6640_CR13","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S2213-8587(22)00244-3","volume":"10","author":"M Fleseriu","year":"2022","unstructured":"Fleseriu M, Langlois F, Lim DST, Varlamov EV, Melmed S (2022) Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol 10:804\u2013826. https:\/\/doi.org\/10.1016\/S2213-8587(22)00244-3","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6640_CR14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11154-020-09588-z","volume":"21","author":"A Giustina","year":"2020","unstructured":"Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, Boguszewski C, Bolanowski M, Bollerslev J, Bonert V, Bronstein MD, Buchfelder M, Casanueva F, Chanson P, Clemmons D, Fleseriu M, Formenti AM, Freda P, Gadelha M, Geer E, Gurnell M, Heaney AP, Ho KKY, Ioachimescu AG, Lamberts S, Laws E, Losa M, Maffei P, Mamelak A, Mercado M, Molitch M, Mortini P, Pereira AM, Petersenn S, Post K, Puig-Domingo M, Salvatori R, Samson SL, Shimon I, Strasburger C, Swearingen B, Trainer P, Vance ML, Wass J, Wierman ME, Yuen KCJ, Zatelli MC, Melmed S (2020) Multidisciplinary management of acromegaly: a consensus. Rev Endocr Metab Disord 21:667\u2013678. https:\/\/doi.org\/10.1007\/s11154-020-09588-z","journal-title":"Rev Endocr Metab Disord"},{"key":"6640_CR15","doi-asserted-by":"publisher","DOI":"10.3171\/2021.11.JNS212137","author":"X Guo","year":"2022","unstructured":"Guo X, Zhang R, Zhang D, Wang Z, Gao L, Yao Y, Deng K, Bao X, Feng M, Xu Z, Yang Y, Lian W, Wang R, Ma W, Xing B (2022) Determinants of immediate and long-term remission after initial transsphenoidal surgery for acromegaly and outcome patterns during follow-up: a longitudinal study on 659 patients. J Neurosurg. https:\/\/doi.org\/10.3171\/2021.11.JNS212137","journal-title":"J Neurosurg"},{"key":"6640_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000435776","volume":"103","author":"MJ Hannon","year":"2016","unstructured":"Hannon MJ, Barkan AL, Drake WM (2016) The role of radiotherapy in acromegaly. Neuroendocrinology 103:42\u201349. https:\/\/doi.org\/10.1159\/000435776","journal-title":"Neuroendocrinology"},{"key":"6640_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12020-015-0766-8","volume":"52","author":"A Heck","year":"2016","unstructured":"Heck A, Emblem KE, Casar-Borota O, Bollerslev J, Ringstad G (2016) Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly. Endocrine 52:333\u2013343. https:\/\/doi.org\/10.1007\/s12020-015-0766-8","journal-title":"Endocrine"},{"key":"6640_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1365-2265.2011.04286.x","volume":"77","author":"A Heck","year":"2012","unstructured":"Heck A, Ringstad G, Fougner SL, Casar-Borota O, Nome T, Ramm-Pettersen J, Bollerslev J (2012) Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly. Clin Endocrinol (Oxf) 77:72\u201378. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04286.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"6640_CR19","doi-asserted-by":"publisher","DOI":"10.4103\/2152-7806.175896","volume":"7","author":"LC Heringer","year":"2016","unstructured":"Heringer LC, de Oliveira MF, Rotta JM, Botelho RV (2016) Effect of repeated transsphenoidal surgery in recurrent or residual pituitary adenomas: a systematic review and meta-analysis. Surg Neurol Int 7:14. https:\/\/doi.org\/10.4103\/2152-7806.175896","journal-title":"Surg Neurol Int"},{"key":"6640_CR20","doi-asserted-by":"publisher","unstructured":"Katznelson L, Laws ER Jr., Melmed S, Molitch ME, Murad MH, Utz A, Wass JA, Endocrine S (2014) Acromegaly: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 99:3933\u20133951. https:\/\/doi.org\/10.1210\/jc.2014-2700","DOI":"10.1210\/jc.2014-2700"},{"key":"6640_CR21","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1227\/00006123-199310000-00008","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610\u2013617. https:\/\/doi.org\/10.1227\/00006123-199310000-00008","journal-title":"Neurosurgery"},{"key":"6640_CR22","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1507\/endocrj.50.635","volume":"50","author":"M Kurosaki","year":"2003","unstructured":"Kurosaki M, Luedecke DK, Abe T (2003) Effectiveness of secondary transnasal surgery in GH-secreting pituitary macroadenomas. Endocr J 50:635\u2013642. https:\/\/doi.org\/10.1507\/endocrj.50.635","journal-title":"Endocr J"},{"key":"6640_CR23","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1210\/jc.2013-3743","volume":"99","author":"CC Lee","year":"2014","unstructured":"Lee CC, Vance ML, Xu Z, Yen CP, Schlesinger D, Dodson B, Sheehan J (2014) Stereotactic radiosurgery for acromegaly. J Clin Endocrinol Metab 99:1273\u20131281. https:\/\/doi.org\/10.1210\/jc.2013-3743","journal-title":"J Clin Endocrinol Metab"},{"key":"6640_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12902-023-01533-w","volume":"24","author":"SF Maroufi","year":"2024","unstructured":"Maroufi SF, Sabahi M, Aarabi SS, Samadian M, Dabecco R, Adada B, Arce KM, Borghei-Razavi H (2024) Recurrent acromegaly: a systematic review on therapeutic approaches. BMC Endocr Disord 24:13. https:\/\/doi.org\/10.1186\/s12902-023-01533-w","journal-title":"BMC Endocr Disord"},{"key":"6640_CR25","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJMra1810772","volume":"382","author":"S Melmed","year":"2020","unstructured":"Melmed S (2020) Pituitary-tumor endocrinopathies. N Engl J Med 382:937\u2013950. https:\/\/doi.org\/10.1056\/NEJMra1810772","journal-title":"N Engl J Med"},{"key":"6640_CR26","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s11102-012-0457-x","volume":"16","author":"TJ Wilson","year":"2013","unstructured":"Wilson TJ, McKean EL, Barkan AL, Chandler WF, Sullivan SE (2013) Repeat endoscopic transsphenoidal surgery for acromegaly: remission and complications. Pituitary 16:459\u2013464. https:\/\/doi.org\/10.1007\/s11102-012-0457-x","journal-title":"Pituitary"},{"key":"6640_CR27","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1227\/NEU.0b013e3181ec4379","volume":"67","author":"S Yamada","year":"2010","unstructured":"Yamada S, Fukuhara N, Oyama K, Takeshita A, Takeuchi Y (2010) Repeat transsphenoidal surgery for the treatment of remaining or recurring pituitary tumors in acromegaly. Neurosurgery 67:949\u2013956. https:\/\/doi.org\/10.1227\/NEU.0b013e3181ec4379","journal-title":"Neurosurgery"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-025-06640-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00701-025-06640-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-025-06640-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T23:03:08Z","timestamp":1755558188000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00701-025-06640-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6640"],"URL":"https:\/\/doi.org\/10.1007\/s00701-025-06640-2","relation":{},"ISSN":["0942-0940"],"issn-type":[{"type":"electronic","value":"0942-0940"}],"subject":[],"published":{"date-parts":[[2025,8,18]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement to obtain informed consent from participants was waived by the Regional Ethical Committee for Medical and Health Research in South East Norway (REK, application number 615816). The pituitary registry at Oslo University Hospital and the present study were approved by the Data protection officer (Personvernombudet, PVO). Human ethics and consent to participate were therefore not applicable in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"223"}}